Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes

Affiliations

• ¹ Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (R.R., P.C., M.C.P., V.V.).
• ² Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (R.R., P.C., M.C.P., V.V.). Electronic address: paola.cravero@irst.emr.it.
• ³ Outcome research, Healthcare Administration, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (I.M.).
• ⁴ Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (F.F., O.N.).
• ⁵ Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (M.P., A.R., L.T.).
• ⁶ Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (C.M.D., A.G.M.).
• ⁷ Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (C.M.D., A.G.M.); Radiation Oncology, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy (A.G.M.).
• ⁸ Medical Oncology Unit, Department of Specialized, Experimental and Diagnostic Medicine (DIMES), University of Bologna, Bologna, Italy (M.M.).